Neurology Alert – August 1, 2014

August 1, 2014

• Is Stem Cell Transplantation a Viable Treatment Option for CIDP?

  In this small, uncontrolled trial, autologous stem cell transplantation appeared to be efficacious for the treatment of patients with refractory CIDP.

  Read more

• OnabotulinumtoxinA for Treatment of Chronic Migraines

  A pooled analysis of four clinical trials concluded that treatment with onabotulinumtoxinA at doses of 75-260 U administered every 12 weeks for up to five treatment cycles was efficacious, safe, and well tolerated for the prophylaxis of headache in adults with chronic migraine.

  Read more

• Diffusion Tensor MRI Advances Diagnostic Accuracy in ALS

  Diffusion tensor magnetic resonance imaging of the brain and spinal cord, which measures the integrity of white-matter fiber tracks, can improve the sensitivity and specificity of amyotrophic lateral sclerosis diagnosis.

  Read more

• The Neurophysiological Features of Myoclonus-Dystonia

  Myoclonus-dystonia is characterized by specific neurophysiological dysfunctions that appear to be different from the ones seen in other dystonias.

  Read more

• Is Epilepsy Surgery on the Decline?

  In this 20-year, retrospective study, the authors summarize surgical trends in three major German epilepsy centers and identified a declining prevalence of epilepsy surgery from 1998 to 2008.

  Read more

• Atrial Fibrillation and Cryptogenic Stroke: Important New Information

  Ischemic stroke remains a leading cause of death worldwide, and atrial fibrillation is a major risk factor, increasing the risk of ischemic stroke five-fold in those who have a confirmed diagnosis of atrial fibrillation.

  Read more